Overall response rate (ORR) greater than 50% across three assessment criteria Median duration of tovorafenib treatment of 15.8 months as...
Company to present BDTX-1535 dose escalation data in NSCLC at the AACR-NCI-EORTC Conference in October 2023 CAMBRIDGE, Mass. and...
SEATTLE and VANCOUVER, British Columbia, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical...
Data from Phase 3 Trial of NE3107 Presented as Poster at the 148th American Neurological Association Annual Meeting CARSON CITY,...
GOTHENBURG, SE / ACCESSWIRE / September 11, 2023 / IRLAB Therapeutics (STO:IRLAB-A) (FRA:6IRA) Gothenburg, Sweden, September 11, 2023 - IRLAB...
Conversion Follows $1.0 Million Capital Investment in August 2023KANSAS CITY, Kan., Sept. 08, 2023 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ:...
Vancouver, British Columbia--(Newsfile Corp. - September 8, 2023) - CENTR Brands Corp. (CSE: CNTR) (FSE: 303) (OTCQB: CNTRF) ("CENTR" or...
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop® system, the world’s first FDA-cleared...
Innovative recruiting and hiring company leverages new Neural Network Mapping technology of the human brain to increase success rates in...
TeraRecon partners with different vendors to provide precise, AI-supported patient care and expand in the neurological solutions market and other...
Completion of enrollment of study on track by end of 2023Topline data results from interim analysis also on track to...
Fortifeye Vitamins - Introducing rTG Omega 3 Fish OilOCALA, FL / ACCESSWIRE / September 7, 2023 / In a groundbreaking...
Five upcoming scientific presentations will add to the body of evidence supporting the advancement of LX9211 into late-stage development Phase...
CARSON CITY, Nev., Sept. 07, 2023 (GLOBE NEWSWIRE) -- BioVie Inc., (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company...
Funds will advance research into ELI-007, a mutant BRAF-peptide vaccine, and ELI-008, a p53 hotspot mutation-peptide vaccine, with the aim...
Vancouver, British Columbia--(Newsfile Corp. - September 7, 2023) - CENTR Brands Corp. (CSE: CNTR) (FSE: 303) (OTCQB: CNTRF) ("CENTR" or...
SAN FRANCISCO--(BUSINESS WIRE)--TechCrunch Disrupt 2023 will feature cutting-edge technology from 15 tech startups from South Korea. This event is presented...
Ben "Doc" Askins, founder of Anti-Hero's Journey, is a former combat medic using psychedelic-assisted therapy to address the brain changes...
Anecdotal Results of Halberd's Nasal Spray Reveals Demonstrably Significant Reduction of Traumatic Brain Injury MarkersJACKSON CENTER, PA / ACCESSWIRE /...
Revolutionizing Mental Health Care: Clarity Clinic Now Offering Transcranial Magnetic Stimulation (TMS)CHICAGO, IL / ACCESSWIRE / September 5, 2023 /...